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Background: Honey is widely used in folk medicine to treat cough, fever, and inflammation. In this study, the
effect of aerosolised honey on airway tissues in a rabbit model of ovalbumin (OVA)-induced asthma was
investigated. The ability of honey to act either as a rescuing agent in alleviating asthma-related symptoms or as a
preventive agent to preclude the occurrence of asthma was also assessed.
Methods: Forty New Zealand white rabbits were sensitized twice with mixture of OVA and aluminium hydroxide
on days 1 and 14. Honey treatments were given from day 23 to day 25 at two different doses (25% (v/v) and 50%
(v/v) of honey diluted in sterile phosphate buffer saline. In the aerosolised honey as a rescue agent group, animals
were euthanized on day 28; for the preventive group, animals were further exposed to aerosolised OVA for 3 days
starting from day 28 and euthanized on day 31. The effects of honey on inflammatory cell response, airway
inflammation, and goblet cell hyperplasia were assessed for each animal.
Results: Histopathological analyses revealed that aerosolised honey resulted in structural changes of the
epithelium, mucosa, and submucosal regions of the airway that caused by the induction with OVA. Treatment with
aerosolised honey has reduced the number of airway inflammatory cells present in bronchoalveolar lavage fluid
and inhibited the goblet cell hyperplasia.
Conclusion: In this study, aerosolised honey was used to effectively treat and manage asthma in rabbits, and it
could prove to be a promising treatment for asthma in humans. Future studies with a larger sample size and
studies at the gene expression level are needed to better understand the mechanisms by which aerosolised honey
reduces asthma symptoms.Background
Asthma is a chronic inflammatory airway disease that
affects around 300 million people worldwide. According
to a survey conducted in 2006, the prevalence of asthma
among Malaysian adults was about 4.5%, and the rate
was increasing, especially among children [1]. Asthma
accounted for 0.4% of all deaths worldwide, and the
number is increasing annually. In fact, this disease has
become a significant cause of morbidity and mortality in
developed countries [2].
Asthmatic patients usually experience recurrent epi-
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article, unless otherwise stated.coughing, especially at night and early in the morning
[3]. The disease is characterised by variable degrees of
chronic inflammation and airway remodelling. Airway
remodelling refers to alteration of the structure of the
airway, which includes epithelium, mucosa, and sub-
mucosa, leading to thickening of the airway wall [4].
Other important features are goblet cell hyperplasia and
metaplasia, increased smooth muscle mass, bronchial
gland enlargement, angiogenesis, and alteration of the
extracellular matrix components [5,6]. Both goblet cell
metaplasia and bronchial gland enlargement lead to air-
way mucus hypersecretion, which contributes to airway
obstruction [6].
Asthma is thought to occur due to over-expression of
Th2 cytokines such as interleukin (IL)-4, IL-5, and IL-13
[3,7]. Over-expression of IL-4 leads to eosinophilia andCentral Ltd. This is an Open Access article distributed under the terms of the
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whereas IL-5 over-expression is thought to result in an
increased number of eosinophils in the airway, which is
the hallmark of asthma [3]. IL-13 over-expression causes
subepithelial fibrosis, mucus metaplasia, and induced in-
filtration of eosinophils and macrophages into the airways
[6,8]. Over-expression of these Th2 interleukin molecules
results in airway hyperresponsiveness (AHR) [7].
Drug therapy has become the most common treatment
to manage asthma. Examples include short acting β-agonists,
inhaled corticosteroids, and long acting β-agonists. These
drugs alleviate asthmatic attacks by relaxing the airway
smooth muscle. However, asthma attacks and exacer-
bations can still occur, as the treatment does not alter the
underlying pathology [9]. Unfortunately, prolonged use of
drug therapy can cause local and systemic side effects, in-
cluding oral candidiasis, dysphonia, growth failure, accel-
erated loss of bone mass, elevated intraocular pressure,
and mild tachyphylaxis [10]. These problems highlight the
need to find an alternative treatment for asthma with
fewer side effects, and the use of natural products is a
promising approach.
Honey has been widely used as a remedy for treating ail-
ments such as cough, fever, infections, and inflammation.
It is reportedly has antioxidant, anti-immunomodulatory,
and antibacterial effects [11,12]. Although honey is usually
taken orally, inhalation is a more suitable way to adminis-
ter honey to treat asthma; it would ensure that the max-
imum amount of honey is deposited in the airways to treat
the disease. Maksoud and Rahman [13] showed that honey
nebulisation was effective in treating upper acute asthma
in paediatric patients. However, there have been no com-
prehensive studies examining the effect of nebulised honey
(i.e., aerosolised) on pathophysiological changes of the
airway tissues in association with asthma-related features
such as on goblet cell hyperplasia, mucus over-production,
and inflammatory cell responses.
The traditional oral administration of honey routes it
towards the digestive system, therefore delaying its effi-
cacy in treating patients with an acute asthma attack.
Thus, the goal of the present study was to investigate the
effect of aerosolised honey on histopathological changes
of the airway in a rabbit model of ovalbumin (OVA)-
induced chronic lung disease, which mimics the hu-
man condition of asthma. Experiments were conducted
to determine whether aerosolised honey can act as a
rescue agent by reducing asthma-related symptoms and/




This study was conducted in strict accordance with
university guidelines. The protocol was approved by theAnimal Ethics Committee of Universiti Sains Malaysia
(USM/Animal Ethics Approval/2012/(77)(379)).Animals
Forty rabbits (breed: New Zealand white, Oryctolagus
cuniculus; sex: male = 37, female = 3; weight: 2.40 ± 0.56
[mean, standard deviation, SD]) were used in this study.
The rabbits were housed in an air-conditioned room,
kept on a 12 hour light/dark cycle, and had access to
clean food and water.
Animals were divided into eight groups of five rabbits
each. Control groups were treated as follows: group 1,
naïve (normal); group 2, injected intraperitoneally (i.p.)
twice with OVA at days 1 and 14; group 3, i.p. injection
twice with OVA at the same time points, followed by
aerosolised OVA for three consecutive days at day 28 to
day 30; group 4, treated twice with i.p. phosphate buff-
ered saline (PBS) at days 1 and 14 followed by aerosol-
ised PBS for three consecutive days at day 28 to day 30
(the negative control). Asthma was induced in rabbits in
the other groups twice via i.p. injection of OVA at days
1 and 14, and they then were treated as follows: groups
5 and 6, honey at 25% (v/v) and 50% (v/v), respectively,
treatment with aerosolised-honey for five consecutive
days from day 23 to day 27, followed by euthanization,
to test for rescue effects; groups 7 and 8, treatment with
aerosolised honey at the same concentrations and time
period, followed by aerosolised OVA for three consecutive
days from day 28 to day 30, before euthanized on the
following day to test for preventative effects – Figure 1.Experimental protocol
Experiments were followed protocols adopted from El.
Gazzar et al. [14]. Induction of allergic airway inflamma-
tion was performed by i.p. sensitization and airway chal-
lenge through nasal inhalation (Figure 1). Animals in
group 2 were sensitized (i.p.) on days 1 and 14 with
0.1 mg of OVA (Sigma A5503; Sigma-Aldrich, St. Louis,
MO, USA) and 10 mg of aluminium hydroxide (alum)
(donated by the EMAN Testing and Research Laboratory,
School of Pharmaceutical Sciences, Universiti Sains
Malaysia) in 2 ml of PBS. Twenty-four hours after the
second sensitization, animals in group 2 were sacrificed.
Animals in the aerosolised OVA group (group 3) were
further challenged with aerosolised OVA (10 mg/ml) for
3 consecutive days starting from day 28 until day 30.
Aerosolised OVA was generated using an ultrasonic
nebuliser (MabisMistTM, Mabis Healthcare Inc, USA).
Rabbits in the negative control group (group 4) were
treated with both i.p PBS and aerosolised PBS. Rabbits
in groups 3 and 4 were euthanized at day 31 using
intravenous injection of sodium pentobarbital (1 ml/kg
body weight) (Dolethal, Lure Cedex, France).
Figure 1 Procedural timeline. Schematic diagrams showing the procedures and timelines for OVA induction of airway inflammation in the
rabbit model and for treatment with aerosolised honey.
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induced via i.p. OVA in rabbits in groups 5, 6, 7, and 8.
They then were treated for 20 min with 5 ml of aerosol-
ised Tualang honey (Federal Agricultural Marketing
Authority (FAMA) of Malaysia). Honey was diluted with
PBS to either 25% (v/v) or 50% (v/v). Animals in groups
5, 6, 7 and 8 were treated with 25% (v/v) and 50% (v/v)
honey. Treatment was given daily starting from day 23
until day 27. Rabbits in groups 5 and 6 (models of honey
as rescue agent) were euthanized on day 28, whereas
rabbits in groups 7 and 8 (honey as preventive agent) were
subsequently challenged with aerosolised OVA (10 mg/ml)
starting from day 28 until day 30 and euthanized at day 31.
Figure 1 outlines of the study procedures and time points
for each group.
Collection of bronchoalveolar lavage (BAL) fluid
Twenty four hours after the final treatment, rabbits were
anaesthetised and lungs were lavaged three times by in-
stillation and withdrawal of 3 ml of sterile PBS through
an endotracheal tube. BAL fluid from each animal wasplaced in sterile plastic tubes, cooled in ice, and centri-
fuged (1200 × g) at room temperature for 5 min. The
cell pellets were resuspended in 200 μl of sterile PBS.
Total cell counts were determined using a Neubauer
hemocytometer (Marienfeld, Germany). A 10 μl aliquot
of the cell suspension was mixed with 10 μl of Trypan
blue (Gibco-Life Technologies, NY, USA) solution to
allow counting of nucleated cells. For differential cell
counts, 100 μl of the cell suspension were applied to a
slide by cytospinning at 500 rpm for 5 min followed by
staining with Wright-Giemsa solution (Sigma-Aldrich).
Histological and morphometric analyses
The right lung of each rabbit was fixed in 10% (v/v)
formalin overnight and processed according to standard
histological protocols. Tissues ultimately were embedded
in paraffin (Paraplast® Plus, Leica Biosystems, Ayer
Rajah, Singapore) and cut into 3 μm sections with a
rotary microtome (Accu-Cut®, SRM™ 200, Sakura®, CA,
USA). The sections were stained with haematoxylin and
eosin (H&E) (Sigma-Aldrich) to examine the histology of
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ive tissues [15] and with Alcian Blue (AB; Merck, Darm-
stadt, Germany) and Periodic Acid Schiff (PAS; Sigma-
Aldrich) to detect mucus-secreting goblet cells.
The slides stained with H&E (n = 5 for each group)
were analysed for airway tissue structure and morpho-
metric features such as thickness of epithelium, mucosal,
and submucosal regions. For these measurements, pho-
tomicrographs were taken using a DP72 Olympus digital
camera (Tokyo, Japan) attached to an Olympus BX53
microscope. Measurements were taken from five differ-
ent points on larger airways for each slide.
To measure the effect of honey on mucus production,
the numbers of mucus-secreting goblet cells were counted.
The goblet cells were examined in five different fields in
three large lung sections from each animal (n = 5 for each
group). Results were calculated as the number of positively
stained goblet cells within 100 epithelial cells. All slides
were blinded prior to morphometric analysis.
Statistical analyses
Our preliminary results showed that there was no statis-
tically significant difference in terms of the degree of in-
flammatory responses and airway epithelial structures in
both naïve (group 1) and PBS-treated (group 4) groups
(data not shown); therefore, these two groups were com-
bined and served as the control animal group. The i.p.
OVA (group 2) and i.p. + aerosolised OVA (group 3)Figure 2 Effect of aerosolised honey on inflammatory cell response. T
group (a), injury group (b), and 50% honey-treated group (rescue, c; prevent
injury) resulted in greater infiltration of neutrophils (N), eosinophils (Eo),
cells was low (control animal group). Treatment with aerosolised honey reduc
to OVA following treatment elicited the second phase of the inflammatory regroups were combined and were later known as the
OVA-induced injury group.
For statistical analyses, results were compared among
groups to determine the following: (1) the effect of aero-
solised honey on airway structures and the number of
mucus-secreting cells; (2) the effect of aerosolised honey
as rescue and preventive agents; (3) the effect of treat-
ment with 25% (v/v) and 50% (v/v) honey; and (4) the
effect of treatment with 25% (v/v) and 50% (v/v) honey
for both rescue and preventive groups.
Comparisons between groups were made using inde-
pendent t-tests, and the data are presented as means
(SD). A p value of < 0.05 was considered to be signifi-
cant, whereas p < 0.001 was considered to be highly
significant. Statistical analysis was performed using SPSS
Statistics software version 20 (IBM, NY, USA).
Results
Aerosolised honey reduced the inflammatory cell
response
Figure 2 shows the representative microscopic images of
cytospun BAL fluid stained with Wright-Giemsa, and
Table 1 summarises the histopathological examination of
the effect of aerosolised honey on inflammatory cell
response. Exposure to OVA led to the infiltration of
inflammatory cells into the airway, such as eosinophils,
mononuclear cells (lymphocytes and plasma cells), neu-
trophils, and macrophages (Figure 2b). OVA-inducedhe panels show Wright-Giemsa stained BAL fluid from the control
ive, d). Rabbits in the aerosolised OVA group (group 3 – OVA-induced
and macrophages (M), whereas the number of infiltrated inflammatory
ed the infiltration of these inflammatory cells. However, further exposure
action.




Eosinophils Mononuclear Neutrophils Macrophage
Control - - - -
OVA-induced
injury
+++ +++ ++ +++
25% Honey
rescue
++ +++ + ++
25% Honey
preventive
+ + - +
50% Honey
rescue
- - - +
50% Honey
preventive
+ + - ++
Indicator: -(normal), +(mild), ++(moderate), +++(dense).
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chial inflammatory cell infiltration, especially eosinophils
(which are the hallmark of asthma). The accumulation
of eosinophils in the BAL fluid was reduced by treat-
ment with aerosolised honey (Figure 2c). However, further
exposure to aerosolised OVA in the honey preventive
groups led to an increase in infiltration of inflammatory
cells (Figure 2d). Based on the finding as shown in the
Table 1, the honey treatment in the rescue group shows
less numbers of inflammatory cells present as compared
to honey treatment in the preventive group, with 50% of
honey gave a better effect. Nevertheless, this result shows
that treatment with aerosolised honey can reduce the
inflammatory cell response.
Aerosolised honey had a significant effect on airway
structures
OVA treatment led to the infiltration of inflammatory
cells into the peribronchial region of the lungs (Table 1).
The histological appearance of the airway structures in
the injury group differed compared to the morphology
of the airway in the control group. Figure 3 shows repre-
sentative microscopic images of tissue sections from
different groups stained with H&E. The structure of the
epithelial layer was normal and peribronchial cell infil-
tration was absent in lung sections from the control ani-
mal group (Figure 3a). OVA sensitization and repeated
OVA challenge caused thickening of the airway wall, in-
cluding the epithelium, mucosa, submucosa, and smooth
muscle. It was also associated with epithelial folding and
epithelial cell shedding, elongation of cellular epithelial
nuclei, and goblet cell hyperplasia, which causes accumula-
tion of mucus in the lumen of the bronchioles (Figure 3b).
Compared to the OVA-induced injury group, aerosolised
honey at both the 25% and 50% doses in the rescue groups
reduced the infiltration of inflammatory cells in the peri-
bronchial region (Figure 3c, e). In the preventive groups withboth doses of honey, epithelial thickening was increased
compared to that of the control group (Figures 3d, f).
Figure 4 shows (1) OVA induced the development of
epithelial hyperplasia and thickening of mucosal and
submucosal regions and (2) the effect of treatment with
25% and 50% aerosolised honey on airway structures fol-
lowing OVA treatment. Treatment with aerosolised honey
at both concentrations in both the rescue and preventive
experiments restored the airway structures following in-
duction with OVA (Table 2). In all four treatment groups,
honey treatment was significantly reduced the thickness of
the airway epithelial and mucosal regions (p < 0.05) fol-
lowing asthma induction with OVA. However, inhalation
of honey did not significantly restore the submucosal
region (p > 0.05).
Effect of aerosolised honey on goblet cells
Figure 5 shows representative microscopic images of
lung sections stained with AB-PAS. Figure 6 shows the
results of morphometric analysis of the effect of OVA
induction on goblet cell hyperplasia as compared to the
control and aerosolisation of 25% and 50% honey on
goblet cell numbers in different treatment groups. Fol-
lowing OVA sensitization and challenge, AB-PAS posi-
tive goblet cells were significantly more abundant in the
OVA-induced injury group compared to the control
group (Figure 6; Table 3) (p < 0.001). Following honey
inhalation, the numbers of goblet cells were significantly
reduced in all treatment groups (p < 0.05) (Figure 6; Table 3).
Discussion
The aim of the present study was to investigate the
effect of aerosolised honey as an agent to alleviate the
asthma-related histopathological changes that occur in
the rabbit airway following OVA-induced injury. The ef-
fects of aerosolised honey on inflammatory cell response,
histopathological changes of lung tissues, and goblet cell
hyperplasia were assessed. Although many studies have
used mice as a model, we used the rabbit as our model
system to imitate human chronic lung disease because it
is phylogenetically closer to humans and offers a better
understanding of lung structure than smaller animal
models [16].
After asthma was induced by OVA, honey was admin-
istered in the form of aerosol particles through a nebu-
liser. This technique was selected because it ensures
maximum deposition of honey on the surfaces of the
airway. The aerosolised honey particles generated by a
nebuliser are between 1 to 5 μm in size [17]. Adjei et al.
[18] reported that particles must be less than 3 μm in
order to be deposited in the pulmonary zone of the
lungs. Thus, aerosol particles generated by a nebuliser
are small enough to reach the lungs and provide the
optimal effect on the subjects. In comparison to smaller
Figure 3 Effect of aerosolised honey on airway structures in the OVA-induced asthma rabbit model. The panels show H&E stained lung
tissues from the control group (a), OVA-induced injury group (b), 25% honey-treated group (rescue, c; preventive, d), and 50% honey-treated
group (rescue, e; preventive, f). Exposure of the lungs to OVA led to epithelial hypertrophy and peribronchial inflammatory cell infiltration (b). Treatment
with aerosolised honey for three consecutive days following OVA sensitization and before the OVA challenge (honey rescue groups) markedly attenuated
airway inflammation (c and e). However, the subsequent OVA challenge (honey preventive groups) caused epithelial hypertrophy as well as peribronchial
cell infiltration to occur (d and f).
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of aerosol via nasal inhalation led to deposition of more
than 80% of the aerosol particles in the nasal region
[19], thus hindering the effectiveness of the treatment.
The pathogenesis of asthma begins with alteration in
the structure of the airway components, such as thicken-
ing of the epithelial and subepithelial regions [5], epithelial
folding and desquamation [4,6], goblet cell metaplasia,
enlargement of blood vessels [5], increased infiltration of
inflammatory cells, and excessive mucus secretion into
the airways [20]. The results of our study showed that the
OVA sensitization and airway challenge led to thickening
of the epithelial layer, mucosa, and submucosa of the lung
tissues, indicating that OVA treatment effectively estab-
lished the model for airway remodelling in rabbits.In this study, aerosolised honey was used to investigate
the capability of honey to 1) alleviate the effects of asthma
(i.e., a rescue treatment) and 2) assess the potential for
honey to prevent the occurrence of asthma (i.e., a prevent-
ive agent). In general, aerosolised honey treatment (both
25% and 50% for both rescue and preventative treatments)
resulted in a significant decrease in the thickening of the
epithelial and mucosal regions. However, the submucosal
region was not affected by the honey treatment. Thicken-
ing of the mucosal regions depends on thickening of the
epithelial layer, whereas the submucosal region of the
rabbit lung contains no (or less) smooth muscle and sub-
mucosal glands – are the main contributors for submuco-
sal thickening. In summary, both the 25% and 50% honey
treatments significantly alleviated airway inflammation
Figure 4 Effect of aerosolised honey treatment on airway structure. The three parameters measured were (a) epithelial thickness, (b) mucosa
thickness, and (c) submucosa thickness. Statistical analyses were performed to compare: 1) the control animal group with the OVA-induced injury
group and 2) the OVA-induced injury group with different treatment groups. p < 0.05 was considered to be statistically significant.
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true for both the rescue and preventive experiments.
This finding suggests that honey may prove useful in
alleviating asthma-associated histopathological changes
as well as preventing the development of asthma upon
subsequent induction with an allergen.In the present study, some of the lung tissue samples
for all groups showed signs of epithelial desquamation.
This feature is often considered to be a pathological
feature of asthma based on observation of post-mortem
specimens and endobronchial biopsies from asthmatic
patients [7,21]. However, epithelial shedding has also been
Table 2 Statistical summary of the effect of aerosolised honey on airway structure
Treatment Group Lung Structure p-value
Control Animal vs OVA-induced Injury*** Epithelial Thickness 0.000
Control Animal vs OVA-induced Injury*** Mucosal Thickness 0.000
Control Animal vs OVA-induced Injury** Sub Mucosal Thickness 0.003
OVA-induced Injury vs 25% Honey as Rescue Agent*** Epithelial Thickness 0.000
OVA-induced Injury vs 25% Honey as Rescue Agent* Mucosal Thickness 0.018
OVA-induced Injury vs 25% Honey as Rescue Agent# Sub Mucosal Thickness 0.219
OVA-induced Injury vs 50% Honey as Rescue Agent* Epithelial Thickness 0.036
OVA-induced Injury vs 50% Honey as Rescue Agent** Mucosal Thickness 0.009
OVA-induced Injury vs 50% Honey as Rescue Agent# Sub Mucosal Thickness 0.155
OVA-induced Injury vs 25% Honey as Preventive Agent*** Epithelial Thickness 0.000
OVA-induced Injury vs 25% Honey as Preventive Agent** Mucosal Thickness 0.006
OVA-induced Injury vs 25% Honey as Preventive Agent# Sub Mucosal Thickness 0.326
OVA-induced Injury vs 50% Honey as Preventive Agent*** Epithelial Thickness 0.000
OVA-induced Injury vs 50% Honey as Preventive Agent*** Mucosal Thickness 0.000
OVA-induced Injury vs 50% Honey as Preventive Agent# Sub Mucosal Thickness 0.211
OVA-induced Injury vs Honey as Rescue Agent*** Epithelial Thickness 0.000
OVA-induced Injury vs Honey as Rescue Agent** Mucosal Thickness 0.002
OVA-induced Injury vs Honey as Rescue Agent# Sub Mucosal Thickness 0.104
OVA-induced Injury vs Honey as Preventive Agent*** Epithelial Thickness 0.000
OVA-induced Injury vs Honey as Preventive Agent*** Mucosal Thickness 0.000
OVA-induced Injury vs Honey as Preventive Agent# Sub Mucosal Thickness 0.168
OVA-induced Injury vs Honey Treatment*** Epithelial Thickness 0.000
OVA-induced Injury vs Honey Treatment*** Mucosal Thickness 0.000
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nonasthmatic subjects [22]. Hence, the presence of epithe-
lial desquamation may be related to the sampling tech-
nique used [7], and it may have occurred during collection
of the BAL fluid samples in this study. Infiltration of
inflammatory cells into the peribronchial region is thought
to be a pivotal process in the pathogenesis of asthma. In
response to injury, Th2 cells are activated and produce a
large amount of IL-4, IL-5, and IL-13. These cytokines are
responsible for recruiting inflammatory cells such as
eosinophils and macrophages into the bronchial region.
Thus, eosinophilic inflammation is the pathological
hallmark of asthma, as the cells act as effectors in
allergic airway disease by releasing cytotoxic granule
proteins [15,23].
OVA-induced asthma results in chronic airway inflam-
mation and characteristically is associated with infiltration
of lymphocytes, eosinophils, macrophages, and neutro-
phils into the peribronchial region [24]. In our study,
treatment with aerosolised honey decreased the numberof inflammatory cells, especially eosinophils, in the airway
region (Figure 2c; Table 1). Treatment with 25% honey in
the rescue group was more effective at suppressing the
infiltration of eosinophils than treatment with 25% honey
in the preventive group. This suggests that treatment with
honey at 25% concentration effectively reduced the in-
flammatory cell response. In addition, inhalation of honey
prevented the occurrence of asthma in the model system.
The number of infiltrating cells in the 50% dosage group
was lower than that of the 25% dosage group in the
asthma prevention experiment.
The anti-inflammatory effect of honey in both in vivo
and in vitro systems has been described previously. How-
ever, most of these studies focused on the role of honey in
wound healing. Bashkaran et al. [25] assessed the anti-
inflammatory and antioxidant properties of Tualang honey
in treating alkaline injury to the eyes of rabbits and reported
that honey contained an anti-inflammatory component with
an effectiveness comparable to that of conventional treat-
ment. In vitro studies showed that honey types such as
Figure 5 Effect of aerosolised honey treatment on goblet cell hyperplasia. The panels show AB-PAS stained lung tissues from the control
group (a), injury group (b), 25% honey-treated group (rescue, c; preventive, d), and 50% honey-treated group (rescue, e; preventive, f). Arrows in
the figure indicate the accumulation of mucus in the airway lumen, and round-ended arrows indicate representative images of goblet cells.
Figure 6 Effect of aerosolised honey treatment on goblet cell numbers. Results of morphometric analysis of the effect of OVA induction on
goblet cell numbers as compared to control animals and the effect of aerosolisation of 25% and 50% honey in different treatment groups on
goblet cell numbers following OVA-induced injury. p < 0.05 is considered to be statistically significant.
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Table 3 Statistical summary of the effect of aerosolised
honey on goblet cell numbers
Treatment Group p-value
OVA-induced Injury vs Control Animal 0.000
OVA-induced Injury vs 25% Honey as Rescue Agent 0.000
OVA-induced Injury vs 25% Honey as Preventive Agent 0.008
OVA-induced Injury vs 50% Honey as Rescue Agent 0.001
OVA-induced Injury vs 50% Honey as Preventive Agent 0.006
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inflammatory components. Manuka honey was reported to
increase the expression of the pro-inflammatory cytokine
TNF-α as well as anti-inflammatory cytokines such as IL-10,
IL-1ra, and growth factors PDG and TGF-β [26]. Kassim
et al. [28] suggested that the anti-inflammatory properties of
honey may be attributable to its phenolic compounds.
Goblet cells are responsible for secreting mucus on the
surface of the airway. Airway mucus protects the epithelial
surfaces from injury and facilitates the removal of bacter-
ial, cellular, and particulate debris from the lung [29]. In
the case of asthma, goblet cells become hyperplastic, and
a high proportion of goblet cells and submucosal gland
enlargement lead to mucus hypersecretion and contribute
significantly to airflow limitation [6,29]. As shown in
Table 3 and Figure 6, treatment with aerosolised honey
(regardless of dosage and its mechanism of action) signifi-
cantly inhibited (p < 0.05) goblet cell hyperplasia and over-
production of mucus following OVA induction. Thus, the
results indicate that aerosolised honey may have an inhibi-
tory effect on the development of asthma. The ability of
aerosolised honey to eliminate goblet cell hyperplasia and
mucus over-production suggest that honey treatment
has great potential in the management of patients with
asthma, both in terms of prevention of disease and
rescuing patients from symptoms.Conclusion
Herein we demonstrated that treatment with honey at both
concentrations tested effectively inhibited OVA-induced
airway inflammation by alleviating asthma-related histo-
pathological changes in the airway and also prevented the
occurrence of asthma. Inhalation of honey was also found
to effectively eliminate mucus-secreting goblet cell hyper-
plasia. Future studies of these effects at the gene expression
level are needed to better understand the mechanisms by
which aerosolised honey reduces asthma symptoms.Financial disclosure
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